Page last updated: 2024-10-24

chlorambucil and Diabetes Mellitus, Type 1

chlorambucil has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hughes, GS1
Kataria, YP1
O'Brien, TF1

Other Studies

1 other study available for chlorambucil and Diabetes Mellitus, Type 1

ArticleYear
Sarcoidosis presenting as biliary cirrhosis: treatment with chlorambucil.
    Southern medical journal, 1983, Volume: 76, Issue:11

    Topics: Chlorambucil; Diabetes Mellitus, Type 1; Diagnosis, Differential; Humans; Liver; Liver Cirrhosis, Bi

1983